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One of the cellular consequences of nitrosative stress is alkylation damage to DNA. To assess whether
nitrosative stress is registered on the genome of Mycobacterium tuberculosis, mutants lacking an alkylation
damage repair and reversal operon were constructed. Although hypersensitive to the genotoxic effects of
N-methyl-N-nitro-N-nitrosoguanidine in vitro, the mutants displayed no phenotype in vivo, suggesting that
permeation of nitrosative stress to the level of cytotoxic DNA damage is restricted.
During the course of an infection, Mycobacterium tuberculo-
sis is expected to sustain significant levels of nitrosative stress.
Nitrate reductase activity provides endogenous nitrosative
stress through the production of  NO (33). Although ex-
pressed under aerobic and anaerobic conditions, this activity is
required at elevated levels during metabolic adaptation of the
organism to microaerophilia (31) and may serve a respiratory
function within the burgeoning granuloma (32). Exogenous
nitrosative stress increases significantly after the onset of ac-
quired immunity via the production of  NO by activated mac-
rophages (4). The reaction of  NO with O2 produces nitrous
anhydride (3), which nitrosates amines and amides to produce
compounds that are metabolically activated to form potent
DNA alkylating agents (10, 13, 15, 30). As such, alkylation
damage of DNA can be considered a downstream sensor of the
level of nitrosative stress to which a cell is exposed (Fig. 1).
In order to assess the permeation of nitrosative stress to this
level in M. tuberculosis, we set out to develop mutant strains
that would be defective in dealing with the consequences of
alkylation damage. Alkylation of DNA can form cytotoxic (N-
alkylation) or promutagenic (O-alkylation) lesions (30, 34).
Since M. tuberculosis contains an operon of genes predicted to
be involved in the repair (Rv1317c) and reversal (Rv1316c) of
such lesions (5, 9, 16), we constructed deletion mutants in this
operon by two independent strategies (Fig. 2) and investigated
the growth characteristics of the mutant strains in vitro and in
vivo. The SID-H and BS-SK strains both lacked the region of
Adl that contains the acceptor site (in AdaA) for methyl
groups from methyl phosphotriesters and regulates the adap-
tive response (24), as well as the entire AlkA domain. They
also lacked the region of Ogt containing the acceptor site for
alkyl groups from O-alkylated bases (29).
The mutant strains grew normally in vitro (data not shown)
but were hypersensitive to the genotoxic effects of the alkylat-
ing agent N-methyl-N-nitro-N-nitrosoguanidine (MNNG)
(Fig. 3). The viability of both the H37Rv and SID-H strains was
reduced in a dose-dependent manner by lower concentrations
of MNNG, but the mutant strain was ca. 100-fold more sensi-
tive than the wild type to the cytotoxic effects of this compound
(Fig. 3A). The BS-SK strain was found to be similarly hyper-
sensitive to the cytotoxic effects of MNNG (data not shown).
The damage-hypersensitive phenotype of strain SID-H was
consistent with loss of the DNA glycosylase (alkA) component
of adl (14) in the mutant strains. This effect was possibly com-
pounded by inactivation of the adaA component of adl, which
would abrogate the ability of M. tuberculosis to mount an
adaptive response to alkylation damage (24). However, the
functionality of this regulatory pathway has yet to be investi-
gated in M. tuberculosis.
The mutagenic effects of MNNG were assessed from levels
of induced mutation to rifampin resistance in the various
strains. Although the average spontaneous mutation frequency
of the SID-H mutant strain in untreated controls was ca. two-
fold higher than that of H37Rv, this difference was not statis-
tically significant. Both H37Rv and SID-H showed an increase
in the frequency of rifampin resistance following MNNG treat-
ment, but the magnitude of the increase was ca. 100-fold
higher in SID-H over the concentration range tested (Fig. 3B).
This finding is consistent with the functional inactivation of ogt
in the mutant strains, since Rv1316c is the only recognizable
gene for reversing promutagenic, O-alkylation lesions (22) in
M. tuberculosis (16). Rifampin-resistant mutants randomly se-
lected from MNNG-treated and untreated control cultures of
the wild-type and mutant strains were genotyped by PCR am-
plification and sequencing of the rifampin resistance-determin-
ing region of the rpoB gene (21). The spectrum of rpoB muta-
tions induced in SID-H closely matched those observed in
rifampin-resistant clinical isolates of M. tuberculosis (21) and in
mutants selected in vitro (17) and was consistent with the
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FIG. 1. Major types of DNA damage caused by exposure to  NO as a function of the growth stage of M. tuberculosis. The major DNA damage
pathways are indicated by arrows. The relative levels of the precursors of nitrous anhydride (N2O3) and peroxynitrite (ONOO-) are shown for the
acute and stationary phases of growth of M. tuberculosis in the mouse model of infection, where  denotes low and  denotes high.
FIG. 2. Construction of adl-ogt mutants of M. tuberculosis. (A) Genetic organization at the Rv1317c-Rv1316c locus of M. tuberculosis H37Rv,
where rrf and rrl are the 5S and 23S rRNA genes, respectively (5). Intergenic distances (base pairs) are shown beneath the map. Rv1317c is
annotated in the EMBL and Tuberculist databases as “alkA” (5). However, Rv1317c is chimeric (9, 16), comprising 5-terminal adaA (18, 24) and
3-terminal alkA components, and we have thus designated this gene “adl” to denote this fact. (B) Restriction maps and genotypes of the wild-type
and mutant alleles (not drawn to scale). The adl-ogt::hyg allele was delivered on the vector pSDVM, which is a subclone of pGEM3Zf() that
also contained a lacZ gene, whereas the adl-ogt::aph allele was delivered on pBSEB, which is a subclone of ptrpA-1-rpsL (25). Allelic exchange
in M. tuberculosis H37Rv to form the SID-H mutant was performed by using UV-pretreated pSDVM (20), whereas that in streptomycin-resistant
H37Rv to form the BS-SK mutant was carried out with pBSEB by using previously described methods (27). The flanking homologous sequences
carried on the delivery vectors are shown as thick horizontal lines of the indicated sizes (base pairs). The mutant alleles differed in that an
additional 246 bp of the ogt gene were deleted in adl-ogt::aph compared to adl-ogt::hyg. The selectable markers are shown as stippled boxes, and
the thick dashed line in the H37Rv map represents the 1,592-bp KpnI-NotI fragment used as the probe for the Southern blot shown in panel C.
Shown above the wild-type allele is the 4,207-bp KpnI fragment carrying the adl-ogt operon and flanking sequences that was used to genetically
complement the SID-H mutant by single-copy insertion at the attB locus via the integrative delivery vector pAINT (1). Relevant restriction sites
are shown and abbreviated as follows: E, EcoRI; K, KpnI; N, NotI, Ns, NsiI; S, SacI; Sm, SmaI; Sp, SpeI. (C) Genotypic confirmation of the SID-H
mutant by Southern blot analysis. Genomic DNA was digested with SmaI and probed by using the 1,592-bp KpnI-NotI fragment. WT, wild type.
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exacerbation of transition mutagenesis as the predicted conse-
quence of persisting promutagenic lesions (data not shown).
To determine whether the mutation in SID-H exerted polar
effects on neighboring genes, a fragment carrying a wild-type
copy of the adl-ogt operon and flanking sequences (Fig. 2) was
integrated at the attB chromosomal locus of SID-H and the
damage sensitivity and induced mutation frequency of the re-
sulting complemented strain in response to treatment with 3
M MNNG were assessed alongside those of SID-H. Compar-
ison with the data of Fig. 3 revealed that genetic complemen-
tation of SID-H restored the damage sensitivity and the in-
duced mutation frequency to wild-type levels (95%  36%
survival of the treated culture versus the untreated control and
an induced mutation frequency of 5.7 107  0.7 107,
respectively). This result confirmed that the phenotype of the
SID-H mutant was solely attributable to the mutation in the
adl-ogt operon.
To examine whether the alkylation damage repair and re-
versal defects of the adl-ogt mutants would be manifested in
a growth phenotype in vivo, C57BL/6 mice were infected with
SID-H or H37Rv and bacillary loads in the lungs, liver, and
spleen were measured at a relatively early stage of stationary
infection, i.e., 30 days after the infection entered stationary
phase in the lungs. However, no significant differences were
observed in the organ counts from mice infected with the
mutant strain compared to those of the wild-type control (Fig.
4). The BS-SK mutant displayed a similar phenotype in
BALB/c mice: no significant differences in bacillary loads were
observed between the mutant and wild-type strains at relatively
early (days 30 and 55 postinfection) or later (day 104) stages of
stationary infection (data not shown). The phenotype of the
adl-ogt mutant strains thus parallels that of a recA mutant of
M. bovis BCG, which was hypersensitive to DNA damage in
vitro but also displayed no growth impairment in mice (26).
The results of this study suggest that permeation of nitrosa-
tive stress to the level of cytotoxic alkylation damage to the
genome of M. tuberculosis is restricted in vivo, at least up to 15
weeks postinfection in the murine model. Restriction in the
levels of cytotoxic alkylation damage sustained in vivo might be
attributable to the action of defense or detoxification systems,
FIG. 3. Response of M. tuberculosis strains to treatment with MNNG. Logarithmic-phase cultures (10 ml; ca. 107 CFU/ml) were mixed for 1 h
at 37°C with an equal volume of MNNG dissolved in Middlebrook 7H9 broth containing 0.05% Tween. Bacteria were washed four times in
phosphate-buffered saline containing 0.1% Tween 80 and resuspended at ca. 106 CFU/ml in 100 ml of 7H9 medium. (A) Survival. Treated and
washed cells were serially diluted, and aliquots from three or more serial dilutions were plated in duplicate on 7H10 agar. The viability of treated
cultures is shown as a percentage of untreated controls, and the data represent the mean and standard deviation from three independent
experiments. (B) Mutation induction. Treated and washed cells were grown standing at 37°C for 8 to 10 days with daily manual agitation before
being serially diluted and plated on 7H10 agar with or without rifampin at 1 g/ml. Mutation frequencies are shown as the ratio of mutants resistant
to rifampin to the total number of CFU. The data are presented as means and standard errors and are representative of two independent
experiments.
FIG. 4. Virulence of wild-type H37Rv versus that of the SID-H
mutant strain in C57BL/6 mice. Infections were carried out as de-
scribed by Dunn and North (7). Eight-week-old C57BL/6 mice, pur-
chased from Jackson Laboratories (Bar Harbor, Maine), were inocu-
lated via a lateral tail vein with 105 CFU of the H37Rv or SID-H strain
in 0.1 ml of phosphate-buffered saline containing 0.01% Tween 80
(PBS-Tween). Both strains were subcultured in Proskauer and Beck
medium in the presence of 0.01% Tween 80, harvested as a dispersion
culture in log phase (approximately 108 bacteria per ml), subjected to
5 s of ultrasound to break up aggregates, and diluted in PBS-Tween for
injection. At 50 days of infection, livers, spleens, and lungs were har-
vested and homogenized in PBS-Tween and whole-organ homogenates
were subjected to 10-fold serial dilution. The dilutions were plated on
Middlebrook 7H11 agar. CFU were scored after incubation of the
plates for 2 to 3 weeks at 37°C. The results show the average and
standard deviation of four mice per time point.
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which protect against nitrosative stress (2, 8, 11, 12, 19, 23).
Alternatively, the environments encountered by M. tuberculosis
during the course of an infection may not favor alkylation
damage; specifically, at the times of bacillary load determina-
tion,  NO may be preferentially sequestered by O2 
, which
would increase the potential for oxidative (6, 28) rather than
alkylative damage (Fig. 1). An assessment of the growth phe-
notypes of mutant strains defective in the ability to repair
replication-blocking oxidative lesions would be revealing in
this respect. Finally, the alkylating agent(s) generated in M.
tuberculosis might be of the promutagenic rather than the cy-
totoxic type, which could lead to a mutator phenotype without
affecting the bacillary load. The extent of promutagenic dam-
age that may occur and its role in genomic diversification and
the evolution of drug resistance thus remain important areas
for future investigation.
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